Gastrointestinal microbiota and metabolite biomarkers in children with autism spectrum disorders

Biomarkers in Medicine

Volumn 8, Issue 3, 2014, Pages 331-344

  Wang, Lv ^a   Conlon, Michael Allan ^b   Christophersen, Claus Thagaard ^b   Sorich, Michael Joseph ^c   Angley, Manya Therese ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b CSIRO   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

autism spectrum disorder; gastrointestinal; metabolite biomarkers; microbiota

Indexed keywords

ACETIC ACID; ARABINITOL; BUTYRIC ACID; DEL IMMUNE V; DELPRO; GLYCINE DERIVATIVE; INDOLYL 3 ACRYLOYLGLYCINE; LACTOBACILLUS ACIDOPHILUS PROBIOTIC AGENT; LACTOBACILLUS PLANTARUM PROBIOTIC AGENT; PLACEBO; PROBIOTIC AGENT; PROPIONIC ACID; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER;

AKKERMANSIA; AUTISM; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTEROIDES; BIFIDOBACTERIUM; CHILD HEALTH; CLINICAL TRIAL (TOPIC); CLOSTRIDIA; CONSTIPATION; DIARRHEA; DISEASE ASSOCIATION; DISEASE MARKER; FERMENTATION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS; METABOLITE; NONHUMAN; POPULATION ABUNDANCE; REVIEW; URINE LEVEL; CLOSTRIDIUM; COMPLICATION; GASTROINTESTINAL TRACT; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MICROFLORA; PATHOLOGY;

ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CLOSTRIDIUM; CONSTIPATION; DIARRHEA; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; PROBIOTICS;

EID: 84898473918     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.14.12     Document Type: Review

References (98)

1. Elsabbagh M, Divan G, Koh YJ et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res. 5(3), 160-179 (2012).
2. Hallmayer J, Cleveland S, Torres A et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 68(11), 1095-1102 (2011).
3. Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tyson Tildon J. Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr. 135(5), 559-563 (1999).
4. Lucarelli S, Frediani T, Zingoni AM et al. Food allergy and infantile autism. Panminerva Med. 37(3), 137-141 (1995).
5. James SJ, Cutler P, Melnyk S et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80(6), 1611-1617 (2004).
6. Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol. Motil. 23(3), 187-192 (2011).
7. WHO. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. WHO, Geneva, Switzerland (1992).
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (3rd Edition). American Psychiatric Association, DC, USA (1980).
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Association, Washington DC, USA (1994).
10. Van Oudenhove L, Demyttenaere K, Tack J, Aziz Q. Central nervous system involvement in functional gastrointestinal disorders. Best Pract. Res. Clin. Gastroenterol. 18(4), 663-680 (2004).
11. Altaf MA, Sood MR. The nervous system and gastrointestinal function. Dev. Disabil. Res. Rev. 14(2), 87-95 (2008).
12. Sullivan PB. Gastrointestinal disorders in children with neurodevelopmental disabilities. Dev. Disabil. Res. Rev. 14(2), 128-136 (2008).
13. Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE. Psychosocial aspects of the functional gastrointestinal disorders. Gut 45(Suppl. 2), II25-II30 (1999).
14. Larsen N, Vogensen FK, Van Den Berg FW et al. Gut microbiota in human adults with Type 2 diabetes differs from non-diabetic adults. PLoS ONE 5(2), e9085 (2010).
15. Arumugam M, Raes J, Pelletier E et al. Enterotypes of the human gut microbiome. Nature 473(7346), 174-180 (2011).
16. Wu GD, Chen J, Hoffmann C et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334(6052), 105-108 (2011).
17. Huse SM, Ye Y, Zhou Y, Fodor AA. A core human microbiome as viewed through 16S rRNA sequence clusters. PLoS ONE 7(6), e34242 (2012).
18. Nicholson JK, Holmes E, Kinross J et al. Host-gut microbiota metabolic interactions. Science 336(6086), 1262-1267 (2012).
19. Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dore J. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl. Environ. Microbiol. 66(5), 2263-2266 (2000).
20. Kelly D, King T, Aminov R. Importance of microbial colonization of the gut in early life to the development of immunity. Mutat. Res. 622(1-2), 58-69 (2007).
21. Yatsunenko T, Rey FE, Manary MJ et al. Human gut microbiome viewed across age and geography. Nature 486(7402), 222-227 (2012).
22. David LA, Maurice CF, Carmody RN et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505(7484), 559-563 (2013).
23. De Filippo C, Cavalieri D, Di Paola M et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl Acad. Sci. USA 107(33), 14691-14696 (2010).
24. O'Keefe SJ. Nutrition and colonic health: the critical role of the microbiota. Curr. Opin. Gastroenterol. 24(1), 51-58 (2008).
25. Sokol H, Pigneur B, Watterlot L et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105(43), 16731-16736 (2008).
26. Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol. 4(11), 430-435 (1996).
27. McKay DM. Intestinal inflammation and the gut microflora. Can. J. Gastroenterol. 13(6), 509-516 (1999).
28. Bjarnason I, Macpherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 108(5), 1566-1581 (1995).
29. Garvey J. Diet in autism and associated disorders. J. Fam. Health Care 12(2), 34-38 (2002).
30. Heijtz RD, Wang S, Anuar F et al. Normal gut microbiota modulates brain development and behavior. Proc. Natl Acad. Sci. USA 108(7), 3047-3052 (2011).
31. Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol. Motil. 23(3), 255-264, e119 (2011).
32. Ledochowski M, Sperner-Unterweger B, Fuchs D. Lactose malabsorption is associated with early signs of mental depression in females: a preliminary report. Dig. Dis. Sci. 43(11), 2513-2517 (1998).
33. Ledochowski M, Widner B, Sperner-Unterweger B, Propst T, Vogel W, Fuchs D. Carbohydrate malabsorption syndromes and early signs of mental depression in females. Dig. Dis. Sci. 45(7), 1255-1259 (2000).
34. Finegold SM. Desulfovibrio species are potentially important in regressive autism. Med. Hypotheses 77(2), 270-274 (2011).
35. Finegold SM, Dowd SE, Gontcharova V et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16(4), 444-453 (2010).
36. Finegold SM, Molitoris D, Song Y et al. Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 35(Suppl. 1), S6-S16 (2002).
37. Song Y, Liu C, Finegold SM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl. Environ. Microbiol. 70(11), 6459-6465 (2004).
38. Parracho HM, Bingham MO, Gibson GR, McCartney AL. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J. Med. Microbiol. 54(Pt 10), 987-991 (2005).
39. Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA. Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl. Environ. Microbiol. 77(18), 6718-6721 (2011).
40. Kang DW, Park JG, Ilhan ZE et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS ONE 8(7), e68322 (2013).
41. De Angelis M, Piccolo M, Vannini L et al. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS ONE 8(10), e76993 (2013).
42. Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA. Gastrointestinal flora and gastrointestinal status in children with autism - comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 11(1).
43. Williams BL, Hornig M, Buie T et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS ONE 6(9), e24585 (2011).
44. Williams BL, Hornig M, Parekh T, Ian Lipkin W. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. mBio 3(1), 1-11 (2012).
45. Bolte ER. Autism and Clostridium tetani. Med. Hypotheses 51(2), 133-144 (1998).
46. Sokol H, Seksik P, Furet JP et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15(8), 1183-1189 (2009).
47. Parracho HMRT, Gibson GR, Knott F, Bosscher D, Kleerebezem M, McCartney AL. A double-blind, placebocontrolled, crossover-designed probiotic feeding study in children diagnosed with autistic spectrum disorders. Int. J. Probiotics Prebiotics 5(2), 69-74 (2010).
48. Lutgendorff F, Akkermans LM, Soderholm JD. The role of microbiota and probiotics in stress-induced gastro-intestinal damage. Curr. Mol. Med. 8(4), 282-298 (2008).
49. Golnik AE, Ireland M. Complementary alternative medicine for children with autism: a physician survey. J. Autism Dev. Disord. 39(7), 996-1005 (2009).
50. Sandler RH, Finegold SM, Bolte ER et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J. Child Neurol. 15(7), 429-435 (2000).
51. Kaluzna-Czaplinska J, Blaszczyk S. The level of arabinitol in autistic children after probiotic therapy. Nutrition 28(2), 124-126 (2012).
52. West R, Roberts E, Sichel L, Sichel J. Improvements in gastrointestinal symptoms among children with autism spectrum disorder receiving the Delpro® probiotic and immunomodulator formulation. J. Prob. Health 1(102), doi:10.4172/jph.1000102 (2013) (Epub ahead of print).
53. Wexler HM. Bacteroides: the good, the bad, and the nittygritty. Clin. Microbiol. Rev. 20(4), 593-621 (2007).
54. Gondalia SV, Palombo EA, Knowles SR, Austin DW. Gastrointestinal microbiology in autistic spectrum disorder: a review. Rev. Med. Microbiol. 21(3), 44-50 (2010).
55. Hsiao EY, McBride SW, Hsien S et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155(7), 1451-1463 (2013).
56. Shimeld LA, Rodgers AT. Essentials of Diagnostic Microbiology. Delmar Cengage Learning, CT, USA (1999).
57. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22, 283-307 (2002).
58. Mazmanian SK, Kasper DL. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat. Rev. Immunol. 6(11), 849-858 (2006).
59. Hopkins MJ, MacFarlane GT. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J. Med. Microbiol. 51(5), 448-454 (2002).
60. Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA. Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. Dig. Dis. Sci. 57(8), 2096-2102 (2012).
61. Boesten RJ, De Vos WM. Interactomics in the human intestine: Lactobacilli and Bifidobacteria make a difference. J. Clin. Gastroenterol. 42(Suppl. 3), S163-S167 (2008).
62. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease. BMC Microbiol. 8, 232 (2008).
63. Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. Fecal beta-d-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig. Dis. Sci. 42(4), 817-822 (1997).
64. Malinen E, Rinttila T, Kajander K et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am. J. Gastroenterol. 100(2), 373-382 (2005).
65. Ono S, Komada Y, Kamiya T, Shirakawa S. A pilot study of the relationship between bowel habits and sleep health by actigraphy measurement and fecal flora analysis. J. Physiol. Anthropol. 27(3), 145-151 (2008).
66. Pabst MJ, Beranova-Giorgianni S, Krueger JM. Effects of muramyl peptides on macrophages, monokines, and sleep. Neuroimmunomodulation 6(4), 261-283 (1999).
67. Souders MC, Mason TB, Valladares O et al. Sleep behaviors and sleep quality in children with autism spectrum disorders. Sleep 32(12), 1566-1578 (2009).
68. Corazziari ES. Intestinal mucus barrier in normal and inflamed colon. J. Pediatr. Gastroenterol. Nutr. 48(Suppl. 2), S54-S55 (2009).
69. Belzer C, De Vos WM. Microbes inside - from diversity to function: the case of Akkermansia. ISME J. 6(8), 1449-1458 (2012).
70. Van Passel MW, Kant R, Zoetendal EG et al. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS ONE 6(3), e16876 (2011).
71. De Magistris L, Familiari V, Pascotto A et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J. Pediatr. Gastr. Nutr. 51(4), 418-424 (2010).
72. D'eufemia P, Celli M, Finocchiaro R et al. Abnormal intestinal permeability in children with autism. Acta Paediatr. 85(9), 1076-1079 (1996).
73. Robertson MA, Sigalet DL, Holst JJ, Meddings JB, Wood J, Sharkey KA. Intestinal permeability and glucagon-like peptide-2 in children with autism: a controlled pilot study. J. Autism Dev. Disord. 38(6), 1066-1071 (2008).
74. Miller RS, Hoskins LC. Mucin degradation in human colon ecosystems. Fecal population densities of mucin-degrading bacteria estimated by a 'most probable number' method. Gastroenterology 81(4), 759-765 (1981).
75. Cummings JH, MacFarlane GT. The control and consequences of bacterial fermentation in the human colon. J. Appl. Bacteriol. 70(6), 443-459 (1991).
76. Wang L, Angley MT, Gerber JP, Sorich MJ. A review of candidate urinary biomarkers for autism spectrum disorder. Biomarkers 16(7), 537-552 (2011).
77. Yap IK, Angley M, Veselkov KA, Holmes E, Lindon JC, Nicholson JK. Urinary metabolic phenotyping differentiates children with autism, from their unaffected siblings and age-matched controls. J. Proteome Res. 9(6), 2996-3004 (2010).
78. Shaw W. Increased urinary excretion of a 3-(3-hydroxyphenyl)- 3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia. Nutr. Neurosci. 13(3), 135-143 (2010).
79. Altieri L, Neri C, Sacco R et al. Urinary p-cresol is elevated in small children with severe autism spectrum disorder. Biomarkers 16(3), 9 (2011).
80. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 81(3), 1031-1064 (2001).
81. MacFabe DF, Cain DP, Rodriguez-Capote K et al. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav. Brain Res. 176(1), 149-169 (2007).
82. El-Ansary AK, Ben Bacha A, Kotb M. Etiology of autistic features: the persisting neurotoxic effects of propionic acid. J. Neuroinflammation 9(1), 74 (2012).
83. MacFabe DF. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb. Ecol. Health Dis. doi:10.3402/mehd. v3423i3400.19260 (2012) (Epub ahead of print).
84. MacFabe DF. Autism: metabolism, mitochondria, and the microbiome. Global Adv. Health Med. 2(6), 15 (2013).
85. Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim. Biophys. Acta 1801(11), 1175-1183 (2010).
86. Shultz SR, MacFabe DF, Martin S et al. Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impair cognition and sensorimotor ability in the Long-Evans rat: further development of a rodent model of autism. Behav. Brain Res. 200(1), 33-41 (2009).
87. MacFabe DF, Rodraguez-Capote K, Hoffman JE et al. A novel rodent model of autism: Intraventricular infusions of propionic acid increase locomotor activity and induce neuroinflammation and oxidative stress in discrete regions of adult rat brain. Am. J. Biochem. Biotechnol. 4(2), 146-166 (2008).
88. MacFabe DF, Cain NE, Boon F, Ossenkopp KP, Cain DP. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav. Brain Res. 217(1), 47-54 (2011).
89. Frye RE, Melnyk S, MacFabe DF. Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder. Transl. Psychiatry 3, e220 (2013).
90. Ramakrishna BS, Gee D, Weiss A, Pannall P, Roberts-Thomson IC, Roediger WE. Estimation of phenolic conjugation by colonic mucosa. J. Clin. Pathol. 42(6), 620-623 (1989).
91. Birkett AM, Jones GP, Muir JG. Simple high-performance liquid chromatographic analysis of phenol and p-cresol in urine and feces. J. Chromatogr. B Biomed. Appl. 674(2), 187-191 (1995).
92. Persico AM, Napolioni V. Urinary p-cresol in autism spectrum disorder. Neurotoxicol. Teratol. 36, 82-90 (2013).
93. Clark-Taylor T, Clark-Taylor BE. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase. Med. Hypotheses 62(6), 970-975 (2004).
94. Filipek PA, Juranek J, Nguyen MT, Cummings C, Gargus JJ. Relative carnitine deficiency in autism. J. Autism Dev. Disord. 34(6), 615-623 (2004).
95. Meletis CD, Zabriskie N. Supporting gastrointestinal health with nutritional therapy. Alternat. Complement. Ther. 14(3), 132-138 (2008).
96. Clayton TA. Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism. FEBS Lett. 586(7), 956-961 (2012).
97. Mazefsky CA, Schreiber DR, Olino TM, Minshew NJ. The association between emotional and behavioral problems and gastrointestinal symptoms among children with highfunctioning autism. doi:10.1177/1362361313485164 Autism (2013) (Epub ahead of print).
98. Galli-Carminati G, Chauvet I, Deriaz N. Prevalence of gastrointestinal disorders in adult clients with pervasive developmental disorders. J. Intellect. Disabil. Res. 50(Pt 10), 711-718 (2006).